-
- Jeffrey I. Cohen
- National Institute of Allergy and Infectious Diseases (NIAID), U.S. National Institutes of Health (NIH), Bethesda, MD 20892, USA.
-
- Anthony S. Fauci
- National Institute of Allergy and Infectious Diseases (NIAID), U.S. National Institutes of Health (NIH), Bethesda, MD 20892, USA.
-
- Harold Varmus
- National Cancer Institute, NIH, Bethesda, MD 20892, USA.
-
- Gary J. Nabel
- National Institute of Allergy and Infectious Diseases (NIAID), U.S. National Institutes of Health (NIH), Bethesda, MD 20892, USA.
説明
<jats:p>Clinical studies should focus on prevention of Epstein-Barr virus–associated cancers and infectious mononucleosis, facilitated by identification of disease-predictive surrogate markers.</jats:p>
収録刊行物
-
- Science Translational Medicine
-
Science Translational Medicine 3 (107), 107fs107-, 2011-11-02
American Association for the Advancement of Science (AAAS)
